Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
The trial included over 3,400 people with a BMI of 30 or above (or 27+ with at least one weight-related health condition) and without type 2 diabetes
Medicines for Human Use (Clinical Trials) Regulations UK Statutory Instrument 2004/1031
If you have questions about pricing or need assistance, please contact our office for personalized support
WHO and EMA Warnings About Semaglutide and NAION In June 2025, the World Health Organization alerted healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide medications, including Ozempic, Rybelsus, and Wegovy
US$ 23.18
US$ 28.02
US$ 25.90
US$ 22.37
US$ 20.24
